What is ImmunityBio, Inc.'s goodwill?

ImmunityBio, Inc. (IBRX) reported goodwill of $910K in Q1 2026.

How has ImmunityBio, Inc.'s goodwill changed year-over-year?

ImmunityBio, Inc.'s goodwill decreased by 0.0% year-over-year, from $910K to $910K.

What is the long-term trend for ImmunityBio, Inc.'s goodwill?

Over 2 years (2023 to 2025), ImmunityBio, Inc.'s goodwill has grown at a -76.9% compound annual growth rate (CAGR), from $17.09M to $910K.

What does goodwill mean?

The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.

ImmunityBio, Inc. IBRX Goodwill

Goodwill at other companies

Bristol-Myers SquibbBMY

$21.74B0.0%

Johnson & JohnsonJNJ

$48.56B+9.2%

Merck & Co.MRK

$21.58B-0.5%

Gilead SciencesGILD

$8.31B0.0%

Summit TherapeuticsSMMT

$1.97M+2.2%

IncyteINCY

$133M-14.5%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s goodwill?: ImmunityBio, Inc. (IBRX) reported goodwill of $910K in Q1 2026.
How has ImmunityBio, Inc.'s goodwill changed year-over-year?: ImmunityBio, Inc.'s goodwill decreased by 0.0% year-over-year, from $910K to $910K.
What is the long-term trend for ImmunityBio, Inc.'s goodwill?: Over 2 years (2023 to 2025), ImmunityBio, Inc.'s goodwill has grown at a -76.9% compound annual growth rate (CAGR), from $17.09M to $910K.
What does goodwill mean?: The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.